• Home
  • Search
  • P-2263. Are you PRePared After Transplant?
  • https://doi.org/10.1093/ofid/ofae631.2416Copy DOI Icon

P-2263. Are you PRePared After Transplant?

Show More
  • Abstract
  • Literature Map
  • Similar Papers
Abstract

Abstract Background Solid organ transplantation (SOT) is a life-saving medical procedure that can improve the quality of life of individuals with end-stage organ failure. Given the scarcity of organs, it is important to safeguard those implanted and prevent infections. Transplant Infectious Disease physicians help mitigate infectious risk both before and after surgery. One important preventable infection is Human Immunodeficiency Virus (HIV). Pre-exposure prophylaxis (PrEP) is effective in reducing the risk of HIV infection. Yet no study has examined PrEP use in SOT patients. The CDC reports that 30% of patients that may benefit from PrEP are prescribed them in the US. No similar statistic exists for SOT patients. Figure 1 Demographics for SOT patients with possible exposure to HIV. Purple represents those without PrEP. Green represents those with PrEP. Methods To obtain quantitative support for further study, a large, multi-center database (Trinetx) was queried. Trinetx contains deidentified data from hundreds of international healthcare organizations (HCOs) dating back about seven years. The retrospective query included 68 HCOs with patients that met the following search inclusion criteria (based on ICD codes): SOT patient without the diagnosis of HIV, prescribed PrEP, and possible exposure risk for HIV. Results 147,145 SOT patients were identified that did not carry the diagnosis of HIV. Only 160 patients (0.11%) were prescribed PrEP, identified as the following three regimens: tenofovir alafenamide + emtricitabine, tenofovir disoproxil + emtricitabine, or cabotegravir. To risk-stratify HIV exposure, the original cohort of 147,475 SOT patients without HIV were analyzed with ICD codes for HIV exposure. This search identified 2,565 patients coded for HIV exposure. Given that only 160 patients were prescribed PrEP in the cohort, 2,405 patients may have benefited from PrEP but were not prescribed these medications. Patients on PrEP after SOT were predominantly male (78%) and White/Caucasian (58%). Identifying as Asian was a significant factor in using PrEP after SOT (p< 0.0001). Female gender was a significant demographic not utilizing PrEP despite possible exposure to HIV (p< 0.0001). (Figure 1). Conclusion This large database study shows that PrEP is underutilized in SOT patients. Further study—including surveys of sexual practices, provider knowledge, and attitudes towards PrEP, as well as single-center analysis—is needed. Disclosures All Authors: No reported disclosures

Similar Papers
  • Research Article
  • Citations10

Pre-exposure Prophylaxis Use History in People With Antiretroviral Resistance at HIV Diagnosis: Findings From New York City HIV Surveillance and Partner Services, 2015-2022.

  • Nov 17, 2023
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • Kavita Misra +5
  • Research Article
  • Citations6

HIV Treatment, Preexposure Prophylaxis, and Drug Resistance: Reconciling Conflicting Predictions From Mathematical Models

  • Oct 16, 2013
  • Journal of Infectious Diseases
  • J T Okano +1
  • Research Article
  • Citations4

Community Health Care Providers' Perspectives on Human Immunodeficiency Virus Pre-Exposure Prophylaxis Use Among Black Women in Eastern Virginia.

  • Mar 01, 2024
  • AIDS patient care and STDs
  • Kayla Pitchford +4
  • Research Article
  • Citations5

Donor evaluation in the era of HIV-positive organ transplantation: The importance of the infectious diseases specialist.

  • May 08, 2020
  • American Journal of Transplantation
  • Marion Hemmersbach-Miller +2
  • Research Article
  • Citations1

HIV Linkage to Care and Pre-Exposure Prophylaxis Among Persons in Non-Health Care Sites Who Are Tested for HIV for the First Time, United States, 2019.

  • Aug 31, 2022
  • Journal of Public Health Management & Practice
  • John Beltrami +4
  • Research Article
  • Citations5

Barriers and facilitators in pre-exposure prophylaxis (PrEP) use intention among Chinese homosexual men

  • Aug 15, 2020
  • Global Health Journal
  • Mingyu Si +6
  • Research Article
  • Citations18

Rates of New Human Immunodeficiency Virus (HIV) Diagnoses After Reported Sexually Transmitted Infection in Women in Louisiana, 2000-2015: Implications for HIV Prevention.

  • Apr 12, 2019
  • Clinical Infectious Diseases
  • Daniel R Newman +3
  • Research Article
  • Citations2

Trends Analysis of Sexually Transmitted Infections Before and After Human Immunodeficiency Virus Pre-exposure Prophylaxis in the United States 2001–2022

  • Aug 18, 2025
  • Open Forum Infectious Diseases
  • Zailing Xing +1
  • Dissertation
  • Citations1

Increasing the Prescribing of Pre-Exposure Prophylaxis (PrEP) With a Pre-Exposure Prophylaxis Screening Tool

  • Dec 01, 2022
  • Cassey Hall
  • Research Article
  • Citations2

Sexually Transmitted Infection Testing, Prevalence, and Treatment Among Individuals Receiving HIV Preexposure Prophylaxis Within an Integrated Healthcare Delivery System.

  • Jun 17, 2022
  • Sexually Transmitted Diseases
  • Mark A Schmidt +5
  • Research Article
  • Citations14

Perspectives on HIV pre-exposure prophylaxis (PrEP) implementation in Mississippi among Black women and clinical staff: Recommendations for clinical trauma-informed programs

  • Nov 04, 2023
  • Preventive Medicine Reports
  • Tiara C Willie +11
  • Research Article
  • Citations428

HIV Preexposure Prophylaxis, by Race and Ethnicity — United States, 2014–2016

  • Oct 19, 2018
  • Morbidity and Mortality Weekly Report
  • Ya-Lin A Huang +4
  • Research Article
  • Citations36

Missed Opportunities to Prescribe Preexposure Prophylaxis in South Carolina, 2013-2016.

  • May 22, 2018
  • Clinical Infectious Diseases
  • Dawn K Smith +4
  • Research Article

Young people’s attitudes to Pre-Exposure Prophylaxis for HIV Prevention – a qualitative exploratory study

  • Nov 30, 2023
  • International Journal of Pharmacy Practice
  • A P Rathbone +8
  • Research Article
  • Citations16

Preexposure Prophylaxis for HIV Infection

  • Sep 05, 2012
  • JAMA
  • Robert Steinbrook
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.